Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 26
Selected: 0
NCT IDTitle
NCT02443116Study of NGM282 in Patients With Nonalcoholic Steatohepatitis (NASH)
NCT04068896Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination Therapy
NCT05215574Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors
NCT04828265Study of Aldafermin (NGM282) in Healthy Adult Male Japanese and Non-Japanese Subjects
NCT06654726A Multi-center Evaluation of Aldafermin in a Randomized, Double-blind, Placebo-controlled Study in Subjects With Primary Sclerosing Cholangitis.
NCT07033026An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia.
NCT02708576Phase 1 Study of NGM313 in Healthy Adult Participants
NCT02649062Study of NGM282 in Subjects With Functional Constipation and Healthy Individuals
NCT04179630Study of Aldafermin (NGM282) in Participants With Impaired Renal Function
NCT04465955A Study of NGM621 in Participants With Geographic Atrophy
NCT02026401Phase 2 Study of NGM282 in Patients With Primary Biliary Cirrhosis
NCT04823702Study of Aldafermin (NGM282) in Participants With Impaired Hepatic Function
NCT03298464Study of NGM313 in Obese Participants
NCT02704364A Study of NGM282 in Patients With Primary Sclerosing Cholangitis
NCT04913337Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies
NCT03912532Evaluation of Efficacy, Safety and Tolerability of Aldafermin in a Phase 2b, Randomized, Double-blind, Placebo-controlled, Multi-center Study In Subjects With Nonalcoholic Steatohepatitis and Stage 2/3 Fibrosis (ALPINE 2/3)
NCT04187339Study of NGM395 in Adult Participants
NCT04582318A Phase 1/2 Study to Assess the Safety, Tolerability and Pharmacokinetics of NGM621 in Healthy Subjects, and to Assess the Safety, PK and Efficacy in Subjects With Moderate to Severe ARDS Caused by COVID-19
NCT02135536Phase 2b Study of NGM282 Extended Treatment in Patients With Primary Biliary Cirrhosis
NCT03392116Single and Multiple Ascending Dose Study of NGM120 in Healthy Adult Subjects
NCT05311618Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors
NCT04014777Study of NGM621 in Participants With Geographic Atrophy
NCT05130047Aldafermin (NGM282) for Chronic Diarrhea Due to Bile Acid Malabsorption (BAM)
NCT01776528Phase 1 SAD and MAD Study of NGM282 in Healthy Adult Participants
NCT04210245Study of Aldafermin (NGM282) in Subjects With Compensated Cirrhosis (ALPINE 4)
NCT01943045Phase 2 Study of NGM282 in Patients With Type 2 Diabetes